Suchergebnisse - "Nagasaka, Kenji"

PubPharm (14)

1

Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population

enthalten in: Frontiers in immunology | 2023

von Kawasaki, A. | Sada, K. | Kusumawati, P. | +17

2

Association of TERT and DSP variants with microscopic polyangiitis and myeloperoxidase-ANCA positive vasculitis in a Japanese population : a genetic association study

enthalten in: Arthritis research & therapy | 2020

von Kawasaki, A. | Namba, N. | Sada, K. | +16

3

Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population

enthalten in: Scientific reports | 2019

von Yokoyama, N. | Kawasaki, A. | Matsushita, T. | +39

4

Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis

enthalten in: Annals of the rheumatic diseases | 2019

von Namba, N. | Kawasaki, A. | Sada, K. | +21

5

Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases : results from a non-blinded, randomized controlled trial

enthalten in: Arthritis research & therapy | 2017

von Utsunomiya, M. | Dobashi, H. | Odani, T. | +23

6

Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases : a large-scale prospective cohort study

enthalten in: The Journal of rheumatology | 2015

von Yamazaki, H. | Sakai, R. | Koike, R. | +24

7

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice : results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

enthalten in: Arthritis research & therapy | 2015

von Sakai, R. | Cho, S. | Nanki, T. | +46

8

A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan

enthalten in: Modern rheumatology | 2014

von Cho, S. | Sakai, R. | Nanki, T. | +58

9

Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections

enthalten in: Annals of the rheumatic diseases | 2013

von Nanki, T. | Onoue, I. | Nagasaka, K. | +9

10

Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis

enthalten in: Arthritis care & research | 2012

von Sakai, R. | Komano, Y. | Tanaka, M. | +45